Dementia is currently the leading cause of death for women in Australia.
One in four people aged 85+ are affected by dementia, 500,000 of us live with the disease and 1.6 million of us are carers.
So it’s a topic that runs deep in the lives of so many Australians, including my family.
My beautiful Mum was diagnosed with dementia (Alzheimers) in 2017.
She’s in a sort of liminal space right now, caught between two worlds as the disease finds its way through the wormholes of her mind.
Her dementia is winding the tape backwards, fast erasing her memories one by one: the highs of youth, the scars of loss, the best and worst of life’s moments - dementia simply wipes the score.
So these days, Mum and I spend many hours in the half-light of broken conversations, thoughts cut short, the hanging pause of words unfound.
I bring her fresh flowers and ripe fruit. We play the old songs, the big operas, Lloyd-Webber and Strauss, and hum along. We look at old photos or the TV or at the clouds, watch the sky change, see the trees sway: all the small things, all the small noticings now.
Sometimes she is with me, sometimes she is not. I’ve had to learn to meet her anew, to begin again and again, to cherish the small moments we still have, in this slow letting go.
There is currently no cure for dementia.
But the Federal Government has just funded a national bio-medical technology incubator $50 million to develop commercial innovations to address dementia and cognitive decline - to hopefully fund a much-needed cure.
Dr Chris Nave, Chief Executive of Brandon BioCatalyst, and Dr Kaele Stokes, Executive Director of Services, Advocacy and Research at Dementia Australia joined us on Australian Broadcasting Corporation (ABC) recently to discuss the alarming increase of dementia in Australia now - and the research and breakthrough innovations that are (hopefully) coming next.
LISTEN: https://lnkd.in/gJkghqQu
#abcnews #dementia #startups #biotech
Brandon Capital #abc Andy Park ABC RN Drive
Strategy, Technology, Product and Payer Partnerships. Scaled multiple pre-revenue start ups to successful exits. Board Experience, President, CTO, CPO, CSO.
1mo